Pfizer 2 + 1 booster “neutralizes” Omicron variant

A man looking through a microscope.

Photo: Pfizer Pfizer today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable…

Read More

NEW: CDC recommends immunocompromised get additional vaccine 28 days after 2nd vaccine

RINewsToday

COVID-19 Vaccines for Moderately to Severely Immunocompromised People What You Need to Know People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised…

Read More

Boosters begin at nursing homes. Brown Univ. gets $4.9M from CDC to study how immunity fades with age.

RINewsToday

Photo: Brown University Boosters begin at RI nursing homes. Brown University research showed the CDC how immunity fades with age, over time. It’s been approximately 8 or 9 months since most nursing home/long term care/congregate care residents received their second vaccination. Most having received their first and second shots from outside pharmacy/medical partners – a…

Read More

FDA Fully Approves First COVID-19 Vaccine – Pfizer, now known as Comirnaty

RINewsToday

Note: Approx. 30% of those not vaccinated said they would become vaccinated as soon as the vaccine became approved. That just happened. Further approval should be given for Moderna soon. Booster shot approval should also be approved in the near future. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine…

Read More